


HPV16 E7 Antibody (716-325) is a mouse monoclonal IgG2a kappa light chain antibody that detects the E7 protein of HPV-16 origin by western blotting (WB), immunoprecipitation (IP), and enzyme-linked immunosorbent assay (ELISA). Anti-HPV16 E7 antibody (716-325) is available in a non-conjugated form, specifically designed for researchers studying the role of the E7 protein in oncogenesis. The E7 protein is a small zinc-binding phosphoprotein that plays a critical role in the regulation of the cell cycle by interacting with the retinoblastoma tumor suppressor protein (pRb). This interaction leads to the disruption of pRb′s function, promoting uncontrolled cell proliferation, a hallmark of cancer. The E7 protein contains a conserved LXCXE motif that is essential for binding to pRb, and high-risk HPV E7 proteins, such as HPV16 E7, exhibit a significantly higher affinity for pRb compared to their low-risk counterparts. This increased binding affinity facilitates the degradation of Rb family proteins, further enhancing the oncogenic potential of HPV16. The presence of the casein kinase II phosphorylation site within the E7 protein also suggests that post-translational modifications may play a role in activity and stability, making E7 a vital target for therapeutic intervention in HPV-related malignancies. Given the strong association of HPV16 and HPV18 with cervical, vaginal, and vulvar cancers, HPV16 E7 monoclonal antibody (716-325) is an invaluable tool for researchers investigating the molecular mechanisms of HPV-induced tumorigenesis.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
HPV16 E7 Antibody (716-325) | sc-51951 | 100 µg/ml | $322.00 | |||
HPV16 E7 Antibody (716-325): m-IgG Fc BP-HRP Bundle | sc-536851 | 100 µg Ab; 10 µg BP | $361.00 | |||
HPV16 E7 Antibody (716-325): m-IgGκ BP-HRP Bundle | sc-534018 | 100 µg Ab; 40 µg BP | $361.00 | |||
HPV16 E7 Antibody (716-325): m-IgG2a BP-HRP Bundle | sc-547883 | 100 µg Ab; 10 µg BP | $361.00 |